Skip to main content
Have a personal or library account? Click to login
Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression Cover

Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression

Open Access
|Oct 2009

References

  1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.1997; 33: 1075-107.
  2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and Neck Cancer.2001; 345: 1890-900.
  3. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer.2009; 45: 201-11.
  4. Samardziski M, Zafiroski G, Tolevska C, Kalicanin-Markovska M, Doncovska D, Anevska V, et al. Treatment of patients with "high grade" extremity localized chondrosarcoma. Preliminary results.2009; 43: 187-94.
  5. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer.2004; 51: 334-40
  6. Oblak I. Anderluh F, Velenik V. Postoperative radiochemotherapy for gastric adenocarcinoma: long term results.2009; 43: 274-81.
  7. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract.1990; 160: 405-9.
  8. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity.1990; 66: 109-13.
  9. Shah JP, Andersen PE. The impact of patterns of nodal metastasis on modifications of neck dissection.1994; 1: 521-32.
  10. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF. Radiotherapy for oral cancer as a risk factor for second primary cancers.2005; 220: 185-95.
  11. Ni Choileain N, Redmond HP. Cell response to surgery.2006; 141: 1132-40.
  12. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation.1996; 20: 454-9.
  13. Weese JL, Ottery FD, Emoto SE. Do operations facilitate tumor growth? An experimental model in rats.1986; 100: 273-7.
  14. Sietses C, Beelen RH, Meijer S, Cuesta MA. Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications.1999; 384: 250-8.
  15. Carter JJ, Whelan RL. The immunologic consequences of laparoscopy in oncology.2001; 10: 655-77.
  16. Stavrev P, Schinkel C, Stavreva N, Fallone BG. How well are clinical gross tumor volume DVHs approximated by an analytical function?2009; 43: 132-5.
  17. Hellman S. Principles of cancer management: radiation therapy. In: De Vita Jr. VT, Hellman S, Rosenberg SA, editors.. 5th Edit. New York: Lippincot-Raven; 1997. p. 303-33.
  18. Purdy JA, Klein EE. Photon external beam dosimetry and treatment planning. In: Perez CA, Brady LW, Halperin EC, editors.. Philadelphia: Lippincot Williams&Wilkins; 2008. p. 166-89.
  19. Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications.1989; 16: 25-36.
  20. Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy.2003; 55: 1216-25.
  21. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al, editors.. 6th Edit. New York: Springer; 2002.
  22. Smeele LE, Irish J, Gullane PJ, Neligan P, Brown DH, Rotstein LE. A retrospective comparison of the morbidity and cost of different reconstructive strategies in oral andoropharyngeal carcinoma.1999; 109: 800-4.
  23. Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.2002; 112: 1221-9.
  24. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.2006; 42: 131-8.
  25. Becker A, Stadler P, Lavey RS, Hänsgen G, Kuhnt T, Lautenschläger C, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas.2000; 46: 459-66.
  26. van Acht MJ, Hermans J, Boks DE, Leer JWH. The prognostic value of hemoglobin and a decrease hemoglobin during radiotherapy in laryngeal carcinoma.1992; 23: 229-35.
  27. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.1998; 42: 1069-75.
  28. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.1953; 26: 638-48.
  29. Vaupel P, Kelleher D, Höckel M. Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.2001; 28: 29-35.
  30. Brand A, Houbiers JGA. Clinical studies of blood transfusion and cancer. In: E.C. Vamvakas and M.A. Blajchman, editors.. AABB Press; 1999, 145-190.
  31. Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma.1987; 113: 307-10.
  32. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck.1990; 116: 304-9.
  33. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.2006; 42: 131-8.
  34. Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the university of California, San Francisco (UCSF) and Stanford university hospital (SUH) experience.2001; 50: 1172-80.
  35. Velenik V. Locally recurrent rectal cancer: treatment options.2009; 43: 144-51.
  36. Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy.2003; 50: 452-8.
  37. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count.1999; 245: 295-300.
  38. Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma.2007; 43: 283-8.
  39. Scully C. Immunological abnormalities in oral carcinoma and oral keratosis.1982; 10:113-5.
  40. Khanna NN, Das SN, Khanna S. Serum immunoglobulins in squamous cell carcinoma of the oral cavity.1982; 20: 46-8.
  41. Brivio F, Lissoni P, Tisi E, Erba L, Barni S, Tancini G, et al. Effects of a preoperative therapy with IL-2 on surgery induced lymphocytopenia in cancer patients.1992; 49: 215-8.
  42. Brivio F, Lissoni P, Tisi E, Erba L, Barni S, Tancini G, et al. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients.1992; 49: 215-8.
  43. Hamid J, Bancewicz J, Brown R, Ward C, Irving MH, Ford WL. The significance of changes in blood lymphocyte populations following surgical operations.1984; 56: 49-57.
  44. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL: Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.2004; 10: 3755-62.
  45. Uh S, Lee SM, Kim HT, Chung Y, Kim YH, Park C, et al. The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma.1994; 105: 132-7.
  46. Lissoni P, Meregalli S, Bonetto E, Mancuso M, Brivio F, Colciago M, et al. Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms.2005; 19: 153-8.
  47. Gray WC, Hasslinger BJ, Suter CM, Blanchard CL, Goldstein AL, Chretien PB. Suppression of cellular immunity by head and neck irradiation. Precipitating factors and reparative mechanisms in an experimental model.1986; 112: 1185-90.
  48. Verastegui EL, Morales RB, Barrera-Franco JL, Poitevin AC, Hadden J. Long-term immune dysfunction after radiotherapy to the head and neck area.2003; 3: 1093-104.
  49. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery.1992; 111: 201-9.
  50. Kallio R, Bloigu A, Surcel HM, Syrjälä H. C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas.2001; 9: 124-8.
  51. Brigden ML. Clinical utility of the erythrocyte sedimentation rate.1999; 60: 1443-50.
  52. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.2001; 182: 197-201.
  53. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer.1998; 176: 335-8.
  54. Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer.1999; 82: 107-10.
  55. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma.2009; 45: 912-4.
  56. Lewis, S.M. Erythrocyte sedimentation rate and plasma viscosity.. Broadsheet 94, June 1980.
  57. Hart GD, Soots M, Sullivan J. Significance of extreme elevation of erythrocyte sedimentation rate.1970; 12: 12-3.
  58. Tang JT, Yamazaki H, Nishimoto N, Inoue T, Nose T, Koizumi M, et al. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma.1996; 16: 2005-8.
  59. Koc M, Taysi S, Sezen O, Bakan N. Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy.2003; 26: 1494-7.
  60. Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy.2001; 49: 1093-6.
  61. Nimmerjahn F, Ravetch JV. Fcγ receptors: old friends and new family members.2006; 24: 19-28.
  62. Radaev S, Sun P. Recognition of immunoglobulins by Fcγ receptors.2002; 38: 1073-83.
  63. Guyre PM, Campbell AS, Kniffin WD, Fanger MW. Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors.1990; 86: 1892-6.
  64. Herra CM, Keane CT, Whelan A. Increased expression of Fcgamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection.1996; 44: 135-40.
  65. Leino L, Sorvajarvi K, Katajisto J, Laine M, Lilius EM, Pelliniemi TT, et al. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo.1997; 107: 37-43.
  66. Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).2001; 125: 258-65.
  67. Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes.2008; 2008: 2026-46.
  68. Hiesmayr MJ, Spittler A, Lassnigg A, Berger R, Laufer G, Kocher A, et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery.1999; 115: 315-23.
  69. Fjaertoft G, Håkansson LD, Pauksens K, Sisask G, Venge P. Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.2007; 39: 525-35.
  70. Nieto A, Sánchez MJ, Martínez C, Castellsagué X, Quintana MJ, Bosch X, et al. Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits.2003; 89: 1667-71.
  71. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008; 42: 69-81.
  72. Jurdana M. Cancer cachexia-anorexia syndrome and skeletal muscle wasting.2009; 43: 65-75.
DOI: https://doi.org/10.2478/v10019-009-0034-8 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 282 - 292
Published on: Oct 26, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Tadej Dovšak, Alojz Ihan, Vojislav Didanovič, Andrej Kansky, Nataša Hren, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.